Skip to content

What are the effects of training on thought processes and symptoms in persons with depression?

Effects of cognitive control training plus bias modification for depressed and anxious patients in comparison with a placebo group

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58765041
Enrollment
180
Registered
2021-11-24
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder, generalized anxiety disorder Mental and Behavioural Disorders

Interventions

This study is a three-armed, double-blinded randomized control trial that, to assess the mechanisms of change, compares the efficacy of cognitive control training and bias modification in Major Depres
First et al., 2015), will be used, as well as, the Patient Health Questionnaire-9 (PHQ-9
Kroenke et al., 2001) and the Generalized Anxiety Disorder-7 (GAD-7
Spitzer et al., 2006). In the baseline assessment, all participants will complete the PHQ-9 (Kroenke et al., 2001), GAD-7 (Spitzer et al., 2006), and the Regulation Emotion System Sur
De France & Hollenstein, 2017). This will be followed, in the same session, by an assessment of attention

Sponsors

Instituto Superior da Maia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over 18 years old. 2. Be fluent in Portuguese. 3. Normal or corrected normal vision. 4. Meet the criteria for Major Depressive Disorder or Generalized Anxiety Disorder for inclusion in the clinical groups. In turn, for the inclusion in the Healthy Adults group participants must not have any psychological diagnose.

Exclusion criteria

Exclusion criteria: 1. Meet the criteria for substance abuse, bipolar disorder, and any psychotic disorder or symptoms. 2. Active suicidal ideation or a previous suicide attempt.

Design outcomes

Primary

MeasureTime frame
1. Depression symptoms are measured with the Patient Health Questionnaire-9, in all groups and conditions, in the screening, baseline, intervention, and follow-up stages to assess the development of depressive symptoms. 2. Anxiety symptoms is measured using the Generalize Anxiety Disorder-7 in all the sessions and in all groups and conditions. 3. Attentional bias is measured using a Dot-Probe Task in the baseline, intervention, and follow-up stages. 4. Interpretation bias is measured with the Scrambled Sentences Test at baseline, intervention, and follow-up stages. 5. Working memory is measured with the N-back task at baseline, during intervention and follow-up stages.

Secondary

MeasureTime frame
1. Emotion regulation strategies are measured with the Regulation Emotion System Survey at baseline, during intervention and follow-up stages. 2. Memory bias is measured with the Self-Referent Encoding Task at baseline, during intervention and follow-up.

Countries

Portugal

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026